Professional Documents
Culture Documents
Drug Study March 03 2011
Drug Study March 03 2011
College of Nursing
Drug Study Name/Section: GARCIA, Jan Isaiah S. 4BCN Group 6A March 03, 2011 Trade Name: Demerol Hydrochloride Pregnancy Category: C
Adverse Reactions Transient hallucinati ons Transient hypotensi on in high doses Visual disturban ces Active metabolit e may accumula te in renal dysfunctio n, leading to an increased risk of CNS toxicity Drug Interactions Drug-Drug: Protease Inhibitors: Avoid combination Sibutramine: Possibility of lifethreatening serotonin syndrome Tricyclic Antidepressant s: Additive anticholinergic side effects Cimetidine: Increase respiratory and CNS depression Hydantoins: Decrease meperidine effect r/t increased liver breakdown Nursing Considerations Meperidine for IV use is incompatible with: Aminophylline, barbiturates, heparin, iodide, methicillin, Morphine SO4, phenytoin, NaHCO3, sulfadiazine, sulfisoxazole. For repeated doses, IM administration is preferred over SC use More effective when given parenterally than when given PO If used concomitantly with phenothiazines or antianxiety agents, reduce dose by 2025% Health Teachings Drug causes dizziness and drowsiness; do not engage in activities that require mental alertness Take drug within ordered intervals to prevent pain recurring; report pain levels and lack of effectiveness Due to low BP effects, rise slowly and do not change positions abruptly Increase fluid intake and bulk; report constipation if evident Avoid alcohol and other CNS depressant Store safely away from bedside; record dose and time of administration. Drug causes dependence
doses of morphine. Produces both psychologic and physical dependence; overdosage causes respiratory depression.
4BCN
Group 6A
threshold of excitability.Is selective for the uterus, especially towards the end of pregnancy, during labor, and immediately following delivery.
undeliverable without conversion prior to delivery, Fetal distress where delivery is not imminent, cord prolapse, total placenta previa, genital herpes
units/ml) Use Y tubing system, with one bottle containing IV solution and oxytocin, and the other containing only the IV solution.
the release of hypothalamic and hypophyseal hormones; competes with histamine for the H1 receptor
postoperative pain Contraindications: Previous phenothiazine idiosyncrasy or hypersensitivity, SC or intraarterial use d/t tissue necrosis and gangrene, use in the treatment of lower respiratory symptoms, including asthma Lactation, comatose clients, CNS depression due to drugs (including barbiturates, general anesthetics, tranquilizers, alcohol, narcotics)
when promethazine is combined with antihistamines, anticholinergics such as atropine and other phenothiazines Promethazine may interfere with urinary pregnancy tests leading to falseresults
situation Do not confuse promethazine with chlorpromazine or with prochlorperazine, both of which are antipsychotics Decrease dosage in dehydrated or oliguric clients Ampules may contain sulfite. Inject IM deep into large muscle mass rotating sites. Not for SC or intra-arterial administration; may cause tissue necrosis
adequate fluids to prevent dehydration; use caution in hot weather to prevent heat stroke Report any involuntary muscle movement. Keep all F/U appointments
Drug
smooth muscle to stimulate the rate, tone and amplitude of uterine contractions. It induces a rapid, sustained tetanic uterotonic effect that shortens the third stage of labor and reduces blood loss. The uterus becomes more sensitive to the drug toward the end of pregnancy
prevention of postpartal and postabortal hemorrhage by producing firm uterine contractions and decreasing uterine bleeding During the second stage of labor following delivery of the anterior shoulder, but only under full obstetric observation
Contraindications: To induce labor or threatened spontaneous abortions. Administration before delivery of the placenta. Use with CYP3A4 inhibitors (e.g. protease inhibitors, macrolide antibiotics, azole antifungal drugs) Pregnancy, toxemia, Hypertension. Ergot hypersensitivity.
Seizure HTN associate d with seizure or headache Acute MI Thrombophlebitis Palpitatio n Dizziness H/a Tinnitus
Azole antifungals: Increase risk of vasospasm leading to cerebral ischemia and/or ischemia of the extremities; do not use together Clarithromycin: Increase risk of vasospasm leading to cerebral ischemia and ischemia of the extremities Sympathomimeti cs: HTN r/t additive vasoconstriction Protease Inhibitors: Increase risk of vasospasm leading to cerebral ischemia and ischemia of the extremities
contracture; massage to check for relaxation or severe cramping Administer slowly over 1 minute and check for VS for evidence of shock or HTN after IV administration. Have emergency drugs available Give only if solution is clear and colorless; discard ampoules if discolored Monitor baseline calcium; correct if low to improve drug effectiveness; Monitor prolactin levels; assess for decreased milk production With post partum bleeding, report frequency, amount, color, and any associated S&S.
ergotism (cold, numb finer/toes, N&V, headache, muscle or chest pain, weakness) or infection Take only as directed; do not exceed dosage Avoid smoking; nicotine constricts blood vessels Abdominal cramps may be experienced; report any severe cramping, increased bleeding or adverse effects. Follow up with provider to ensure no complications
4BCN
Group 6A
Nursing Considerations
Buscopan should be used with caution in conditions characterised by tachycardia such as thyrotoxicosis, cardiac insufficiency or failure and in cardiac surgery where it may further accelerate the heart rate. Due to the risk of anticholinergic complications, caution should be used in patients susceptible to intestinal or urinary outlet obstructions. Because of the possibility that anticholinergics may reduce sweating, Buscopan should be administered with caution to patients with pyrexia. Elevation of intraocular pressure may be produced by the administration of anticholinergic agents such as Buscopan in patients with undiagnosed and therefore untreated narrow angle glaucoma.
Health Teachings Advise client to report signs and symptoms of adverse reactions such as allergic skin reactions, DOB, visual disturbance Caution patient to avoid alcohol because it may increase CNS depression.
buscopan.
anesthetics, CHF cardiogenic shock, 2nd or 3rd degree AV blocks] Hypovolemia Heartblock Other Conduction Disturbances
respiration, or seizures.
4BCN
Group 6A
Theophylline at low doses changes a sedative effect of diazepam. Cimetidine, omeprazole, disulfiram may increase the intensity and duration of action of diazepam. Simultaneous
Advise patient to report signs and symptoms of diazepam toxicity:CNS depression of varying severity (from lethargy to coma): severe drowsiness, lethargy, weakness, decreased muscle tone, ataxia, prolonged confusion, depression of reflexes, coma; perhaps
CNS. Muscle relaxant effect is also due to the inhibition of spinal reflexes. This medication may cause anticholinergic effects.
Specifying a history of alcohol or drug dependence (except for acute withdrawal). Hypersensitivity to diazepam and other benzodiazepines. Myasthenia gravis, severe chronic hypercapnia.
administration with paracetamol may decrease excretion of diazepam and its metabolite desmethyldiazepam; with risperidone described the cases of NMS. Simultaneous administration with muscle relaxants the action of muscle relaxants increases, also increases the risk of apnea.
not be used in the I trimester of pregnancy, except in cases of extreme necessity. Diazepam taking during pregnancy may significantly change fetal heart rate.
4BCN
Group 6A
results in increased motility of the upper GIT and relaxation of the pyloric sphincter and duodenal bulb. Gastric emptying time and GI transit time are shortened. No effect on gastric, biliary or pancreatic secretions; Facilitates intubation of the small bowel and speeds transit of barium meal. Produces sedation, includes release of prolactin, increases circulating aldosterone levels, an antiemetic
Contraindications: GI hemorrhage, obstruction or perforation Epilepsy Clients taking drugs likely to cause extrapyramidal symptoms such as phenothiazines Pheochromocytoma
decrease metoclopramide effects CNS depressants: additive sedative effects Digoxin: decrease digoxin effect r/t decrease GI absorption Narcotic analgesic: decrease metoclopramide effect Tetracyclines: increase tetracyclines GI absorption
thiazide diuretic) Metoclopramide is physically/chemica lly incompatible with with number of drugs; check package insert if drug is to be admixed Asses abdomen for bowel sounds, distention N&V
response, persistent side effects so they can be properly evaluated and counteracted Avoid alcohol and CNS depressants Extrapyramidal effects ( trembling hands, facial grimacing) should be reported; may be treated with parenteral diphenhydramine